Moleculin Biotech, Inc.
MBRX
$0.77
$0.011.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.26% | -85.82% | -65.84% | -119.73% | -60.81% |
| Total Depreciation and Amortization | -61.48% | -46.40% | -28.57% | -13.85% | -5.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -26.33% | 654.99% | 983.49% | 1,120.15% | 3,187.67% |
| Change in Net Operating Assets | 2.31% | -47.37% | 140.26% | -111.59% | 426.89% |
| Cash from Operations | -18.81% | -11.85% | 4.72% | 5.17% | 15.02% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 38.78% | 112.52% | 485.54% | 129.81% | 357.22% |
| Repurchase of Common Stock | -700.00% | 69.23% | 69.23% | 100.00% | 96.55% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 38.74% | 112.89% | 488.65% | 130.50% | 360.57% |
| Foreign Exchange rate Adjustments | 10.71% | 30.00% | 259.38% | -785.71% | -64.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.03% | 128.56% | 123.87% | 82.19% | 84.58% |